(Q34257815)

31 July 2017

1 reference

title

Cytomegalovirus infection and abdominal pain with mycophenolate mofetil: is there a link? (English)

1 reference

31 July 2017

0 references

cytomegaloviral disease

1 reference

H Gallagher

1

1 reference

31 July 2017

P A Andrews

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

24

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

405-412

1 reference

Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.

31 July 2017

cites work

1 reference

12 December 2020

Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients

1 reference

12 December 2020

Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain

1 reference

12 December 2020

Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection

1 reference

12 December 2020

Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis

1 reference

12 December 2020

Advances in understanding cytomegalovirus infection after transplantation

1 reference

12 December 2020

Cytomegalovirus prophylaxis in solid organ transplant recipients

1 reference

12 December 2020

Non-transplant uses of mycophenolate mofetil

1 reference

12 December 2020

Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group

1 reference

12 December 2020

RS-61443 for treatment-resistant human liver rejection.

1 reference

12 December 2020

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection

1 reference

12 December 2020

Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.

1 reference

12 December 2020

Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients

1 reference

12 December 2020

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group

1 reference

12 December 2020

Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients

1 reference

12 December 2020

CMV infection is associated with transplant renal artery stenosis.

1 reference

12 December 2020

Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients

1 reference

12 December 2020

Increased Pulmonary Superinfections in Cardiac-Transplant Patients Undergoing Primary Cytomegalovirus Infection

1 reference

12 December 2020

Pharmacokinetics of mycophenolate mofetil (RS61443): a short review.

1 reference

12 December 2020

A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group

1 reference

12 December 2020

The evolving role of mycophenolate mofetil in renal transplantation

1 reference

12 December 2020

The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation

1 reference

12 December 2020

Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group

1 reference

12 December 2020

Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation

1 reference

12 December 2020

Primary and Secondary Cytomegalovirus Infection

1 reference

12 December 2020

Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation

1 reference

12 December 2020

Mycophenolate mofetil

1 reference

12 December 2020

Mycophenolate mofetil

1 reference

12 December 2020

Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis

1 reference

12 December 2020

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

1 reference

12 December 2020

Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience

1 reference

12 December 2020

Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil

1 reference

12 December 2020

Mycophenolic acid and its mechanism of action in cancer and psoriasis

1 reference

12 December 2020

Cytomegalovirus: disease syndromes and treatment

1 reference

12 December 2020

Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy

1 reference

12 December 2020

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

1 reference

12 December 2020

Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice

1 reference

12 December 2020

Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects?

1 reference

12 December 2020

Mycophenolate mofetil: a report of the consensus panel.

1 reference

12 December 2020

Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses

1 reference

12 December 2020

Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study

1 reference

12 December 2020

Limited sampling strategy for mycophenolic acid area under the curve

1 reference

12 December 2020

Mycophenolate mofetil-induced villous atrophy

1 reference

12 December 2020

Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety

1 reference

12 December 2020

10.2165/00002018-200124060-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1037054740

0 references

1 reference